Healthcare -
Biotechnology - NASDAQ - US
$ 20.72
-1.57 %
$ 1.8 B
Market Cap
-4.58
P/E
TVTX - CASH FROM OPERATIONS
Cash from Operations TVTX - Travere Therapeutics, Inc.
-280 M
LAST VALUE
-335.09%
2 YEAR CAGR
-62.18%
5 YEAR CAGR
-31.88%
10 YEAR CAGR